Ctt Pharmaceutical

(OTC) CTTH

Current Price$0.08

Market Cap$4.84M

Since IPO (2014)-80%

5 Year+42%

1 Year+51%

1 Month+10%

Ctt Pharmaceutical Financials at a Glance

Market Cap

$4.84M

Revenue (TTM)

$0.00

Net Income (TTM)

$155.91K

EPS (TTM)

$-0.00

P/E Ratio

-29.46

Dividend

$0.00

Beta (Volatility)

-0.55 (Low)

Dividend

$0.00

Beta (Volatility)

-0.55 (Low)

Price

$0.08

Volume

11,000

Open

$0.08

Price

$0.08

Volume

11,000

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.02 - $0.10

Dividend

$0.00

Beta (Volatility)

-0.55 (Low)

Price

$0.08

Volume

11,000

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.08

52-Week Range

$0.02 - $0.10

CTTH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ctt Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Ryan Khouri

Website

www.cttpharmaceuticals.com

Headquarters

Ottawa, ON K2P 2B4, CA

CTTH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-357%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-3.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.84M

Shares Outstanding

58.71M

Volume

11.00K

Avg. Volume

29.96K

Financials (TTM)

Gross Profit

$6.43K

Operating Income

$126.77K

EBITDA

$120.34K

Operating Cash Flow

$75.47K

Capital Expenditure

$3.00

Free Cash Flow

$75.47K

Cash & ST Invst.

$15.36K

Total Debt

$18.81K

Ctt Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$1.63K

+74.5%

Gross Margin

0.00%

N/A

Market Cap

$4.84M

N/A

Market Cap/Employee

$2.42M

N/A

Employees

N/A

Net Income

$50.26K

-713.6%

EBITDA

$13.05K

+93.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.46K

+79.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$18.81K

+11.1%

Return on Assets

-1.81%

N/A

Return on Invested Capital

-2.18%

N/A

Free Cash Flow

$15.28K

-181.9%

Operating Cash Flow

$15.28K

-181.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PCYNProcyon Corporation

PCYNProcyon Corporation$0.20+0.00%

MJNAMedical Marijuana, Inc.

MJNAMedical Marijuana, Inc.$0.00+0.00%

HBRMHerborium Group, Inc.

HBRMHerborium Group, Inc.$0.00+0.00%

BMCSBioTech Medics, Inc.

BMCSBioTech Medics, Inc.$0.00+50.00%

EDXCEndexx Corporation

EDXCEndexx Corporation$0.00+0.00%

SRUTFSproutly Canada Inc.

SRUTFSproutly Canada Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

INTCIntel

INTCIntel$119.84+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

ACHRArcher Aviation

ACHRArcher Aviation$6.36+0.04%

QUBTQuantum Computing

QUBTQuantum Computing$12.31+0.08%

Questions About CTTH

What is the current price of Ctt Pharmaceutical?

Ctt Pharmaceutical is trading at $0.08 per share.

What is the 52-week range for Ctt Pharmaceutical?

Over the past 52 weeks, Ctt Pharmaceutical has traded between $0.02 and $0.10.

How much debt does Ctt Pharmaceutical have?

As of the most recent reporting period, Ctt Pharmaceutical reported total debt of $18,814.

How much cash does Ctt Pharmaceutical have on hand?

Ctt Pharmaceutical reported $15,359 in cash and cash equivalents in its most recent financial results.

What is Ctt Pharmaceutical’s dividend yield?

Ctt Pharmaceutical does not currently have a dividend yield.

Ctt Pharmaceutical

Ctt Pharmaceutical Financials at a Glance

CTTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ctt Pharmaceutical

CTTH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ctt Pharmaceutical Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTTH

What is the current price of Ctt Pharmaceutical?

What is the 52-week range for Ctt Pharmaceutical?

How much debt does Ctt Pharmaceutical have?

How much cash does Ctt Pharmaceutical have on hand?

What is Ctt Pharmaceutical’s dividend yield?

Premium Investing Services